Expressive Constructs, Inc., doing business as ECI Biotech Inc., is structured around development of diagnostic sensors and therapeutics for detecting microbial pathogens and stabilizing active proteins to protect against infection. The firm offers a family of diagnostic sensors that identify signature enzyme targets and substrates using a combination of genomics and biochemical screening; and a family of proteins that prevent damage by blocking upstream mechanisms of pathogen induced apoptosis. With four areas of core competence: molecular biology, genomics, protein expression, and assay development, ECI products pipeline includes a diagnostic sensor for urinary tract infections and also wound care systems that provide early warning of emergent infections and promote healing. Products offered by the firm are incorporated into medical devices and into consumer products, as well as used as point of care diagnostic tools. The company's products are used in feminine care, wound care, oral care, vision care, food safety, and hospital infection control applications.
